<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NYSE:CRL (USA) Also Trade In: Germany

Charles River Laboratories International Inc $ 128.66 -5.62 (-4.19%)

Volume:
857,382
Avg Vol (1m):
319,248
Market Cap $:
6.28 Bil
Enterprise Value $:
8.28 Bil
P/E (TTM):
29.13
P/B:
4.26
Warning! GuruFocus has detected 1 Severe warning sign with CRL. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for CRL (Charles River Laboratories International) from 2000 to Oct 22 2019. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Charles River Laboratories International stock (CRL) PE ratio as of Oct 22 2019 is 29.13. More Details

Charles River Laboratories International PE Ratio (TTM) Chart

EMBED

Charles River Laboratories International PE Ratio (TTM) Historical Data

Total 1252
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Charles River Laboratories International PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2019-10-2229.1 2019-08-2029.3
2019-10-2129.1 2019-08-1929.6
2019-10-1830.4 2019-08-1629.4
2019-10-1730.8 2019-08-1528.9
2019-10-1630.5 2019-08-1428.6
2019-10-1530.3 2019-08-1329.6
2019-10-1430.3 2019-08-1229.4
2019-10-1130.1 2019-08-0930.0
2019-10-1029.6 2019-08-0830.5
2019-10-0929.7 2019-08-0729.9
2019-10-0829.3 2019-08-0629.8
2019-10-0729.8 2019-08-0528.6
2019-10-0429.8 2019-08-0230.1
2019-10-0329.2 2019-08-0130.3
2019-10-0228.6 2019-07-3130.4
2019-10-0129.0 2019-07-3031.9
2019-09-3030.0 2019-07-2931.6
2019-09-2730.0 2019-07-2631.7
2019-09-2630.6 2019-07-2531.3
2019-09-2530.8 2019-07-2431.6
2019-09-2431.0 2019-07-2331.1
2019-09-2331.2 2019-07-2230.9
2019-09-2031.4 2019-07-1930.7
2019-09-1931.2 2019-07-1831.1
2019-09-1830.7 2019-07-1730.6
2019-09-1730.4 2019-07-1630.6
2019-09-1630.4 2019-07-1530.8
2019-09-1329.9 2019-07-1230.5
2019-09-1229.8 2019-07-1130.9
2019-09-1129.5 2019-07-1031.2
2019-09-1029.3 2019-07-0931.6
2019-09-0929.4 2019-07-0831.8
2019-09-0630.5 2019-07-0532.2
2019-09-0530.2 2019-07-0432.2
2019-09-0429.8 2019-07-0332.2
2019-09-0329.6 2019-07-0232.0
2019-09-0229.7 2019-07-0132.5
2019-08-3029.7 2019-06-2832.1
2019-08-2929.6 2019-06-2730.2
2019-08-2829.3 2019-06-2629.5
2019-08-2728.7 2019-06-2528.9
2019-08-2628.6 2019-06-2429.6
2019-08-2328.3 2019-06-2129.8
2019-08-2229.2 2019-06-2030.0
2019-08-2129.3 2019-06-1929.6

Charles River Laboratories International PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Medical Diagnostics & Research » Medical Diagnostics & Research NAICS : 541714 NAICS : 8732
Traded in other countries RV6.Germany CRL.USA
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories is a leading provider of drug discovery and development services. With roughly 50% of market share worldwide, the research model and services segment is the leading provider of animal models for laboratory testing. The remainder of Charles River's revenue comes from its preclinical services segment, which offers discovery, toxicology, pathology, and manufacturing testing services to pharmaceutical, biotechnology, and device companies.